Mutual Capital Partners is a venture fund investing in B2B software and medical device companies.
Business Model: B2B Non-Profit
Revenue: $8.3M
Employees: 11-50
Address: 1290 Bassett Road
City: Westlake
State: OH
Zip: 44145
Country: US
Mutual Capital Partners is a venture fund investing in rapidly growing technology businesses generally located in the Midwest. Our investors are successful executives from across the U.S. and we&s;ve combined the best elements of an angel fund into a committed capital, professionally managed venture fund.Due to the lack of venture capital in the Midwest, we created MCP in 2004 to lead or co-lead investments in promising companies looking for capital. Management is a key focus for us and we work with our 100+ investors in our funds to assist us in due diligence, customer introductions, and ongoing advice and counsel to our portfolio executives. MCP is committed to entrepreneurialism working with angel funds, economic development entities, and entrepreneurs to assist them through the capital continuum. We respond to all potential investments within five business days and try to provide feedback or introductions to all companies contacting us.
Contact Phone:
+12165774408
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2015 | 7SIGNAL | Series A | 2.9M |
6/2008 | Mork Process | Series A | 2M |
3/2016 | Cleveland HeartLab | Venture Round | - |
6/2015 | Vox Mobile | Series C | 0 |
6/2009 | OrthoHelix Surgical Designs | Venture Round | 0 |
10/2012 | Cleveland HeartLab | Series B | 14.7M |
1/2023 | Authenticx | Series B | 0 |
2/2011 | OrthoHelix Surgical Designs | Series D | - |
8/2021 | Checkpoint Surgical | Venture Round | 0 |
9/2017 | OrthAlign | Series D | 10M |
9/2018 | Checkpoint Surgical | Series D | 0 |
11/2014 | OrthAlign | Series C | 15M |
4/2017 | 7SIGNAL | Series B | 4.2M |
10/2014 | enosiX | Series A | 4.3M |
3/2018 | 7SIGNAL | Series C | 7M |
4/2010 | OrthoHelix Surgical Designs | Series C | 14M |
4/2021 | EBlu Solutions | Series A | 11.4M |
4/2010 | Hemosphere | Series A | 9.3M |
8/2022 | Redi.Health | Venture Round | 3.7M |
12/2018 | enosiX | Series B | 4.2M |
10/2013 | 7SIGNAL | Series A | 4.1M |
10/2021 | SPR Therapeutics | Series D | 0 |
8/2021 | Redi.Health | Seed Round | 0 |
1/2006 | OrthoHelix Surgical Designs | Series A | 1.7M |
6/2016 | RevLocal | Venture Round | 3.5M |
9/2019 | enosiX | Series A | 4M |
9/2004 | CardinalCommerce | Series A | 3M |
8/2022 | Olio | Series A | 13M |
9/2022 | Elevation Spine | Series B | 0 |
6/2021 | 7SIGNAL | Series D | 0 |
4/2020 | 7SIGNAL | Series D | 0 |
9/2005 | TGX Medical Systems | Series A | 1.5M |
10/2021 | Catalyst OrthoScience | Series D | 12.3M |
5/2019 | Catalyst OrthoScience | Series C | 12.7M |
5/2006 | OrthoHelix Surgical Designs | Series B | 3.3M |
10/2021 | SPR Therapeutics | Series D | 0 |
10/2021 | Catalyst OrthoScience | Series D | 0 |
8/2021 | Redi.Health | Seed Round | 0 |
8/2021 | Checkpoint Surgical | Venture Round | 0 |
6/2021 | 7SIGNAL | Series D | 0 |
4/2021 | EBlu Solutions | Series A | 0 |
4/2020 | 7SIGNAL | Series D | 0 |
9/2019 | enosiX | Series A | 0 |
5/2019 | Catalyst OrthoScience | Series C | 0 |
12/2018 | enosiX | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|